Communications between Gilead and USTR regarding Malaysia compulsory license on HCV patents, 2017 to May 2018
The attached document is a 78 page PDF file obtained from USTR under the Freedom of Information Act (copy here), regarding communications between Gilead and USTR, over Malaysia’s decision to grant a compulsory license on patents for HCV treatments. This… Continue Reading